Search research articles
Contact Us
Filters
Showing results (331-340 of 447) with videos related to
Page
of 45
Sort By:
The Oncologist
|
September 12, 2021
The Relationship Between Frailty and Emotional Health in Older Patients with Advanced Cancer
Nikesha Gilmore, Lee Kehoe, Jessica Bauer, et al.
The Oncologist
|
July 26, 2021
Association Between Caregiver-Oncologist Discordance in Patient's Life Expectancy Estimates and Caregiver Perceived Autonomy Support by the Oncologist
Gina Tuch, Chandrika Sanapala, Supriya G Mohile, et al.
American Heart Journal
|
June 20, 2006
Design and rationale of the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial Veterans Affairs Cooperative Studies Program no. 424
William E Boden, Robert A O'rourke, Koon K Teo, et al.
Elife
|
December 2, 2024
Human airway macrophages are metabolically reprogrammed by IFN-γ resulting in glycolysis-dependent functional plasticity
Donal J Cox, Sarah A Connolly, Cilian Ó Maoldomhnaigh, et al.
The American Journal of Cardiology
|
January 16, 2007
The evolving pattern of symptomatic coronary artery disease in the United States and Canada: baseline characteristics of the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial
William E Boden, Robert A O'rourke, Koon K Teo, et al.
Clinical Colorectal Cancer
|
November 8, 2011
Phase III trial of cetuximab, bevacizumab, and 5-fluorouracil/leucovorin vs. FOLFOX-bevacizumab in colorectal cancer
Leonard Saltz, Suprith Badarinath, Shaker Dakhil, et al.
Cell
|
October 13, 2009
Gabapentin receptor alpha2delta-1 is a neuronal thrombospondin receptor responsible for excitatory CNS synaptogenesis
Cagla Eroglu, Nicola J Allen, Michael W Susman, et al.
Journal of the American College of Cardiology
|
February 14, 1998
Design and baseline characteristics of the Veterans Affairs Non-Q-Wave Infarction Strategies In-Hospital (VANQWISH) trial. VANQWISH Trial Research Investigators
D R Ferry, R A O'Rourke, A S Blaustein, et al.
Circulation. Cardiovascular Quality and Outcomes
|
December 25, 2009
Quantitative results of baseline angiography and percutaneous coronary intervention in the COURAGE trial
G B John Mancini, Eric R Bates, David J Maron, et al.
The New England Journal of Medicine
|
August 16, 2008
Effect of PCI on quality of life in patients with stable coronary disease
William S Weintraub, John A Spertus, Paul Kolm, et al.
Page
of 45
Search research articles
Search
Showing results (331-340 of 447) with videos related to
Sort By:
Page
of 45
The Oncologist
|
September 12, 2021
The Relationship Between Frailty and Emotional Health in Older Patients with Advanced Cancer
Nikesha Gilmore, Lee Kehoe, Jessica Bauer, et al.
The Oncologist
|
July 26, 2021
Association Between Caregiver-Oncologist Discordance in Patient's Life Expectancy Estimates and Caregiver Perceived Autonomy Support by the Oncologist
Gina Tuch, Chandrika Sanapala, Supriya G Mohile, et al.
American Heart Journal
|
June 20, 2006
Design and rationale of the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial Veterans Affairs Cooperative Studies Program no. 424
William E Boden, Robert A O'rourke, Koon K Teo, et al.
Elife
|
December 2, 2024
Human airway macrophages are metabolically reprogrammed by IFN-γ resulting in glycolysis-dependent functional plasticity
Donal J Cox, Sarah A Connolly, Cilian Ó Maoldomhnaigh, et al.
The American Journal of Cardiology
|
January 16, 2007
The evolving pattern of symptomatic coronary artery disease in the United States and Canada: baseline characteristics of the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial
William E Boden, Robert A O'rourke, Koon K Teo, et al.
Clinical Colorectal Cancer
|
November 8, 2011
Phase III trial of cetuximab, bevacizumab, and 5-fluorouracil/leucovorin vs. FOLFOX-bevacizumab in colorectal cancer
Leonard Saltz, Suprith Badarinath, Shaker Dakhil, et al.
Cell
|
October 13, 2009
Gabapentin receptor alpha2delta-1 is a neuronal thrombospondin receptor responsible for excitatory CNS synaptogenesis
Cagla Eroglu, Nicola J Allen, Michael W Susman, et al.
Journal of the American College of Cardiology
|
February 14, 1998
Design and baseline characteristics of the Veterans Affairs Non-Q-Wave Infarction Strategies In-Hospital (VANQWISH) trial. VANQWISH Trial Research Investigators
D R Ferry, R A O'Rourke, A S Blaustein, et al.
Circulation. Cardiovascular Quality and Outcomes
|
December 25, 2009
Quantitative results of baseline angiography and percutaneous coronary intervention in the COURAGE trial
G B John Mancini, Eric R Bates, David J Maron, et al.
The New England Journal of Medicine
|
August 16, 2008
Effect of PCI on quality of life in patients with stable coronary disease
William S Weintraub, John A Spertus, Paul Kolm, et al.
Page
of 45